Epinephrine Nasal Solution - FDA Warning
January 22, 2025
On Jan. 16, 2025, the FDA warned healthcare professionals not to use unapproved epinephrine nasal solutions from BPI Labs and Endo
After notification of any recall, Express Scripts will continue processing new and refill prescriptions with product from non-recalled lots or manufacturers, if available. Please visit the U.S. Food and Drug Administration (FDA) website for the most up-to-date information on drug safety and recalls.
The information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.